98%
921
2 minutes
20
Introduction: Essential tremor (ET) is a neurological disorder primarily characterized by upper limb action tremor. It is widely recognized that the thalamus is implicated in ET pathophysiology, playing a central role in treatment approaches. This study aimed to explore thalamic morphology, assessing macrostructural changes and intrinsic thalamic networks in ET patients.
Methods: A total of 109 ET (41 with and 68 without resting tremor) and 81 healthy controls (HC) were enrolled in the study. An automatic probabilistic segmentation of thalamic nuclei was employed on T1-weighted MRI images using FreeSurfer 7.4. Subsequently, volumetric data were extracted, and graph theoretical analysis was applied on the cortical-thalamic nuclei network, assessing global and local network properties.
Results: No significant differences were observed in the volume of thalamic nuclei between ET patients and HC. ET patients exhibited significant alterations in the global thalamic network, suggesting a less efficient brain network in comparison with HC. ET patients also showed local alterations of thalamic network such as lower eccentricity and path length in the ventral nuclei and reduced efficiency in the pulvinar, indicating a less interconnected network. No significant differences were observed between ET patients with and without rest tremor.
Conclusion: Our study demonstrates reduced global and local efficiency of brain networks in ET patients, suggesting impaired communication and interconnection between brain regions. These findings confirm the involvement of the ventral lateral and pulvinar nuclei as key regions in tremor pathophysiology in ET patients, supporting the targeting of these regions for therapeutic approaches.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11839756 | PMC |
http://dx.doi.org/10.1002/brb3.70346 | DOI Listing |
J Neurosci
September 2025
Lendület Laboratory of Thalamus Research, HUN-REN Institute of Experimental Medicine; Budapest, Hungary
The paraventricular thalamic nucleus (PVT) integrates subcortical signals related to arousal, stress, addiction, and anxiety with top-down cortical influences. Increases or decreases in PVT activity exert profound, long-lasting effects on behavior related to motivation, addiction and homeostasis. Yet the sources of its subcortical excitatory and inhibitory afferents, their distribution within the PVT, and their integration with layer-specific cortical inputs remain unclear.
View Article and Find Full Text PDFBrain Behav
September 2025
Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University(Tongde Hospital of Zhejiang Province), Hangzhou, China.
Background: Mental disorders frequently co-occur with pain, yet pain mechanisms in non-peripheral etiologies (e.g., chronic psychological stress) remain underexplored.
View Article and Find Full Text PDFTremor Other Hyperkinet Mov (N Y)
September 2025
Movement Disorders and Neurodegenerative Diseases Unit, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Mexico.
Clinical Vignette: RNA polymerase III subunit A (POLR3A) related disorders are a group of heterogeneous diseases with a recessive autosomic inheritance. These disorders manifest with distinct clinical features like ataxia, spasticity, hypodontia, hypogonadism, mental retardation and progressive motor decline.
Clinical Dilemma: POLR3A gene mutation can manifest with parkinsonism, dystonia, ataxia and tremor.
Nat Commun
September 2025
Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
We introduce an advanced transcranial ultrasound stimulation (TUS) system for precise deep brain neuromodulation, featuring a 256-element helmet-shaped transducer array (555 kHz), stereotactic positioning, individualised planning, and real-time fMRI monitoring. Experiments demonstrated selective modulation of the lateral geniculate nucleus (LGN) and connected visual cortex regions. Participants showed significantly increased visual cortex activity during concurrent TUS and visual stimulation, with high cross-individual reproducibility.
View Article and Find Full Text PDFJ Clin Neurophysiol
July 2025
Department of Pediatrics, Division of Pediatric Neurology, Childrens Medical Center Dallas, UTSW, Dallas, Texas, U.S.A.
Open label use of therapies with adult indications raises unique challenges in pediatric DRE. The following review details the landscape of pediatric intracranial neuromodulation. Initially, I discuss available evidence in pediatric neuromodulation while detailing the only randomized clinical trial in a pediatric developmental and epileptic encephalopathy.
View Article and Find Full Text PDF